SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-102034
Filing Date
2023-04-14
Accepted
2023-04-14 16:05:53
Documents
9
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d381833ddef14a.htm DEF 14A 365862
2 GRAPHIC g381833bi2.jpg GRAPHIC 1136
3 GRAPHIC g381833biote.jpg GRAPHIC 1909
4 GRAPHIC g381833g22n44.jpg GRAPHIC 63739
5 GRAPHIC g381833inter.jpg GRAPHIC 1026
6 GRAPHIC g381833newt.jpg GRAPHIC 1110
7 GRAPHIC g381833phine.jpg GRAPHIC 893
8 GRAPHIC g381833snap1.jpg GRAPHIC 1551
9 GRAPHIC g381833snap2.jpg GRAPHIC 1368
  Complete submission text file 0001193125-23-102034.txt   468282
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

IRS No.: 851791125 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40128 | Film No.: 23821158
SIC: 2833 Medicinal Chemicals & Botanical Products